Caspofungin for Children with Severe Infections
PK/PD of Caspofungin in Children Severe Infection
Recruiting
Observational Study
Pharmacokinetics
Infection, Fungal
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 3 Months – 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Children's Hospital of Fudan University · Other
Who this trial is looking for
This trial is looking for children in the pediatric intensive care unit who are receiving the drug caspofungin. Participating will help researchers understand how this drug works in children with serious health conditions.
Are You a Good Fit for This Trial?
You may be able to join if
- I am a child receiving caspofungin in the pediatric intensive care unit
You may not be able to join if
- I have not signed the informed consent
- I am participating in other clinical trials
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Caspofungin is an anti-fungal drug mainly metabolized by the liver. The pathophysiological status of children with severe infection will affect the metabolism of caspofungin in the body especially in the case of liver dysfunction. There is little metabolism of caspofungin through the kidney and continuous renal replacement therapy and renal function have little influence on the pharmacokinetics of…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children receiving caspofungin in pediatric intensive care unit
Exclusion Criteria:
* No Informed Consent signed Participate in other clinical trials
Contacts